Avita Medical (RCEL)
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Austral...
- Open
- 8.040
- High
- 8.130
- Low
- 7.920
- Prev. Close
- 8.200
- Volume
- 53.10K
- Turnover
- 426.52K
- Avg Price
- 8.033
- Bid/Ask Ratio
- -22.48%
- Amplitude
- 2.56%
- 52wk High
- 8.350
- Volume Ratio
- 6.26
- Turnover Ratio
- 0.18%
Avita Medical Analyst Rating
View moreForecast & Rating
Aug 7, 2026Price forecast
$8.9811.94%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · 44 minutes ago
RCEL: Sequential growth, margin discipline, and new reimbursement drive optimism for future profitability
- PUBT · 17 hours ago
Avita Medical amends PermeaDerm deal with Stedical, pays USD 500.000 for right to expand exclusive territory
- Price Alert · 2 days ago, 07:29 PM
U.S. stock night trading opened with fluctuations: Avita Medical fell 4.50% in night trading; AXT Company rose 4.31% in night trading
- StockTitan · 2 days ago, 09:00 AM
AVITA Medical to Host Investor Webinar Briefing | RCEL Stock News
- Global Report · Aug 9 at 04:12 AM
Biotech and MedTech Sector Signals Divergent Paths Post-Earnings
- Global Report · Aug 8 at 04:21 AM
The Biotech Divide of 2026: Commercial Titans vs. AI Hopefuls
